Investors looking for a defensive angle in the stock market often turn to healthcare, a sector where demand for services tends to hold up even when broader conditions weaken. The article notes that many pharmaceutical companies also distribute regular dividends, adding another layer of appeal for those seeking steadier cash flow. For investors who prefer diversification and professional security selection, mutual funds can be a practical way to gain exposure to the space.
Three healthcare mutual funds highlighted in the report are Janus Henderson Global Life Sciences Fund, Fidelity Select Health Care, and Vanguard Specialized Portfolios Health Care Fund. Each carries a Zacks Mutual Fund Rank #1, or Strong Buy, and is expected to outperform peers over time. Janus Henderson Global Life Sciences Fund focuses primarily on companies with a life sciences orientation and has a fundamental policy of investing at least a small portion of assets in that area. As of the end of March 2026, the fund held 81 issues, with 8.9% of assets in Eli Lilly. It has posted a three-year annualized return of 13.5%.
Fidelity Select Health Care invests most of its net assets in common stocks of foreign and domestic companies tied to healthcare or medicine, including businesses involved in the design, manufacture, or sale of related products and services. The fund uses fundamental analysis that considers financial condition, industry position, and broader market and economic conditions. Its three-year annualized return stands at 9.8%, and its expense ratio is 0.62%. Vanguard Specialized Portfolios Health Care Fund, meanwhile, concentrates on foreign and domestic companies involved in pharmaceutical and medical supply products and services, as well as hospitals and other healthcare facilities. The report says the fund invests the majority of its net assets in that area, making it another option for investors seeking targeted healthcare exposure.
Overall, the piece presents these funds as ways to participate in a sector that may offer relative resilience compared with more cyclical parts of the market. With healthcare demand remaining comparatively stable and some companies paying dividends, the category can fit investors looking to balance growth potential with a more defensive portfolio approach.
Source: nasdaq.com
